Literature DB >> 26796318

Distinct CPT-induced deaths in lung cancer cells caused by clathrin-mediated internalization of CP micelles.

Yu-Sheng Liu1, Ru-You Cheng, Yu-Lun Lo, Chin Hsu, Su-Hwei Chen, Chien-Chih Chiu, Li-Fang Wang.   

Abstract

We previously synthesized a chondroitin sulfate-graft-poly(ε-caprolactone) copolymer (H-CP) with a high content of poly(ε-caprolactone) (18.7 mol%), which self-assembled in water into a rod-like micelle to encapsulate hydrophobic camptothecin (CPT) in the core (micelle/CPT) for tumor-targeted drug delivery. As a result of the recognition of the micelle by CD44, the micelle/CPT entered CRL-5802 cells efficiently and released CPT efficaciously, resulting in higher tumor suppression than commercial CPT-11. In this study, H1299 cells were found to have a higher CD44 expression than CRL-5802 cells. However, the lower CD44-expressing CRL-5802 cells had a higher percentage of cell death and higher cellular uptake of the micelle/CPT than the higher CD44-expressing H1299 cells. Examination of the internalization pathway of the micelle/CPT in the presence of different endocytic chemical inhibitors showed that the CRL-5802 cells involved clathrin-mediated endocytosis, which was not found in the H1299 cells. Analysis of the cell cycle of the two cell lines exposed to the micelle/CPT revealed that the CRL-5802 cells arrested mainly in the S phase and the H1299 cells arrested mainly in the G2-M phase. A consistent result was also found in the evaluation of γ-H2AX expression, which was about three-fold higher in the CRL-5802 cells than in the H1299 cells. A near-infrared dye, IR780, was encapsulated into the micelle to observe the in vivo biodistribution of the micelle/IR780 in tumor-bearing mice. The CRL-5802 tumor showed a higher fluorescence intensity than the H1299 tumor at any tracing time after 1 h. Thus we tentatively concluded that CRL-5802 cells utilized the clathrin-mediated internalization pathway and arrested in the S phase on exposure to the micelle/CPT; all are possible reasons for the better therapeutic outcome in CRL-5802 cells than in H1299 cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26796318     DOI: 10.1039/c5nr08345a

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  3 in total

1.  Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.

Authors:  Xi He; Kaimin Cai; Yu Zhang; Yifei Lu; Qin Guo; Yujie Zhang; Lisha Liu; Chunhui Ruan; Qinjun Chen; Xinli Chen; Chao Li; Tao Sun; Jianjun Cheng; Chen Jiang
Journal:  ACS Appl Mater Interfaces       Date:  2018-11-09       Impact factor: 9.229

2.  An Acetamide Derivative as a Camptothecin Sensitizer for Human Non-Small-Cell Lung Cancer Cells through Increased Oxidative Stress and JNK Activation.

Authors:  Han-Lin Chou; Yao Fong; Hsin-Hsien Lin; Eing Mei Tsai; Jeff Yi-Fu Chen; Wen-Tsan Chang; Chang-Yi Wu; Hui-Min David Wang; Hurng-Wern Huang; Chien-Chih Chiu
Journal:  Oxid Med Cell Longev       Date:  2016-10-24       Impact factor: 6.543

3.  Multi-Stimuli-Responsive DOX Released from Magnetosome for Tumor Synergistic Theranostics.

Authors:  Ming-Fong Tsai; Yu-Lun Lo; Yuan-Chun Huang; Chun-Chieh Yu; Yi-Ting Wu; Chia-Hao Su; Li-Fang Wang
Journal:  Int J Nanomedicine       Date:  2020-11-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.